Skip to main content
SpringerLink
Log in

Aliskiren and blood pressure control in patients with hypertension

  • Clinical Trials Report
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. O’Brien EO, Barton J, Nussberger J, et al.: Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin converting enzyme inhibitor, or an angiotensin receptor blocker. Hypertension 2007, 49:276–284.

    Article  PubMed  CAS  Google Scholar 

  2. Sealey JE, Laragh JH: Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness. Am J Hypertens 2007, 5:587–597.

    Article  Google Scholar 

Download references

Authors
  1. Donald G. Vidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vidt, D.G. Aliskiren and blood pressure control in patients with hypertension. Current Science Inc 9, 351–352 (2007). https://doi.org/10.1007/s11906-007-0065-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-007-0065-8

Keywords

Search

Navigation